Synergistic effects of neuroendoscopic minimally invasive surgery with mannitol and furosemide in managing hypertensive intracerebral hemorrhage

This study aimed to assess the therapeutic efficacy of neuroendoscopic minimally invasive surgery combined with mannitol and furosemide for treating hypertensive intracerebral hemorrhage. We retrospectively analyzed clinical data from 200 patients with hypertensive intracerebral hemorrhage treated at our hospital between July 2020 and July 2022. The patients were categorized into either the experimental group (undergoing neuroendoscopic minimally invasive surgery combined with mannitol and furosemide) or the control group (undergoing neuroendoscopic minimally invasive surgery alone). Then, we compared the efficacy and impact on patients between the two groups. After treatment, the experimental group exhibited a smaller edema area compared to the control group and a reduced hematoma volume (p < 0.001). The total effective rate was significantly higher in the experimental group compared to the control group (p < 0.05). At 7 days post-treatment, patients in the experimental group demonstrated a significantly lower National Institutes of Health Stroke Scale (NIHSS) score compared to the control group (p < 0.001). Additionally, 3 and 7 days after treatment, levels of lipid peroxidation (LPO), neuron-specific enolase (NSE), and S-100β were significantly lower in the experimental group compared to the control group (p < 0.001). Similarly, carotid total blood flow volume (Q) and blood flow velocity (V) were significantly higher in the experimental group at 3 and 7 days post-treatment, with lower peripheral resistance (R) compared to the control group (p < 0.001). The incidence rate of complications was significantly lower in the experimental group compared to the control group (p < 0.05). The integration of neuroendoscopic minimally invasive surgery with mannitol and furosemide administration demonstrates potential in alleviating brain edema, reducing related cytokine levels, facilitating neurological function recovery, and improving cerebral hemodynamic parameters in hypertensive intracerebral hemorrhage patients. These findings merit clinical promotion and application.

Neuroendoscopic minimally invasive surgery; Mannitol; Furosemide; Hypertensive intracerebral hemorrhage

[1] Li W, Li S, Li L, Yang L, Li Z, Li X, et al. Soyasaponin I alleviates hypertensive intracerebral hemorrhage by inhibiting the renin–angiotensin–aldosterone system. Clinical and Experimental Hypertension. 2023; 45: 2177667.

[2] Chao T, Min Z, Wei L. Meta-analysis of stereotactic hematoma removal and craniotomy hematoma removal in the treatment of hypertensive intracerebral hemorrhage in the elderly. Medicine. 2023; 102: e36533.

[3] Munir CA, Afia F, Saqlain MM. Letter to the editor: use of dyna-computed tomography-assisted neuro endoscopic hematoma evacuation in the treatment of hypertensive intracerebral hemorrhage. Neurosurgical Review. 2023; 46: 278.

[4] Zhu Z, Hao L, Gao L, Li X, Zhao J, Zhang T, et al. Determinants of acute and subacute case-fatality in elderly patients with hypertensive intracerebral hemorrhage. Heliyon. 2023; 9: e20781.

[5] Tian B, Tian B, Zhang Y. The efficacy of mannitol combined with 6-aminocaproic acid in the treatment of patients with cerebral hemorrhage and its impact on immune function. Evidence-Based Complementary and Alternative Medicine. 2022; 2022: 7396310.

[6] Waguespack T, Tucker N, Kimmons L, Jones GM. 994: Impact of early mannitol administration on hematoma size in intracerebal hemorrhage. Critical Care Medicine. 2022; 50: 494.

[7] Wang H, Tian L, Yang H, Chen K. Use of dyna-computed tomography-assisted neuroendoscopic hematoma evacuation in the treatment of hypertensive intracerebral hemorrhage. Neurosurgical Review. 2023; 46: 254.

[8] Zhan Y, Zou X, Wu J, Fu L, Huang W, Lin J, et al. Neuroendoscopy surgery for hypertensive intracerebral hemorrhage with concurrent brain herniation: a retrospective study of comparison with craniotomy. Frontiers in Neurology. 2023; 14: 1238283.

[9] Zhang CY, Wang B, Hua XT, Fan K, Li YF. Serum vascular endothelial growth factor and cortisol expression to predict prognosis of patients with hypertensive cerebral hemorrhage. World Journal of Clinical Cases. 2023; 11: 5455–5461.

[10] Li Q, Chen L. Effect of tibialis anterior muscle resistance training on ankle and foot dorsum extension function in hypertensive cerebral hemorrhage hemiplegia patients: a randomized controlled trial. Medicine. 2023; 102: e33827.

[11] Hongbo H, Xin L. Clinical changes of serum melatonin and ICAM-1 levels in patients with basal ganglia hypertensive intracerebral hemorrhage. Pakistan Journal of Medical Sciences. 2023; 39: 1024–1028.

[12] Anand S, Choudhury SS, Pradhan S, Mulmuley MS. Normotensive state during acute phase of hypertensive intracerebral hemorrhage. Journal of Neurosciences in Rural Practice. 2023; 14: 465–469.

[13] Lv K, Wang Y, Chao H, Cao S, Cao W. Comparison of the efficacy of subosseous window neuro-endoscopy and minimally invasive craniotomy in the treatment of basal ganglia hypertensive intracerebral hemorrhage. Journal of Craniofacial Surgery. 2023; 34: e724–e728.

[14] Yuan H, Feng J, Lin X, Li S. The effect of early vs. late CT-guided stereotactic hematoma aspiration on neurological function recovery in patients with hypertensive cerebral hemorrhage in the basal ganglia: a retrospective comparative cohort study. Annals of Palliative Medicine. 2022; 11: 2923–2929.

[15] Mao J, Xu Z, Sun Z, Xu M, Zhao B, Wei J, et al. The effect of small bone window craniotomy removal on lactic acid and CRP in patients with hypertensive intracerebral hemorrhage in the basal ganglia. Neurology India. 2022; 70: 2047–2052.

[16] Lu W, Wang H, Feng K, He B, Jia D. Neuroendoscopic-assisted versus mini-open craniotomy for hypertensive intracerebral hemorrhage: a retrospective analysis. BMC Surgery. 2022; 22: 188.

[17] Mei L, Fengqun M, Xiaozhuo L, Qing W, Mingming F, Zhengyao Z, et al. Effect western medicines combined with Nao-Xue-Shu in patients with hypertensive intracerebral hemorrhage: a network meta-analysis. Frontiers in Pharmacology. 2022; 13: 892904.

[18] Tingyan Hu, Zhao Y, Hu Z, Zuo C. Clinical effects of piracetam plus mannitol on cerebral edema, neurological function, and vascular endothelin-1 levels following cerebral hemorrhage. Neurochemical Journal. 2023; 17: 156–162.

[19] Schreibman DL, Hong CM, Keledjian K, Ivanova S, Tsymbalyuk S, Gerzanich V, et al. Mannitol and hypertonic saline reduce swelling and modulate inflammatory markers in a rat model of intracerebral hemorrhage. Neurocritical Care. 2018; 29: 253–263.

[20] Maykin MM, Mercer E, Saiki KM, Kaneshiro B, Miller CB, Tsai PS. Furosemide to lower antenatal severe hypertension: a randomized placebo-controlled trial. American Journal of Obstetrics & Gynecology MFM. 2024; 6: 101348.

[21] Liao R, Liu L, Song B, Wan X, Wang S, Xu J. 3D-slicer software-assisted neuroendoscopic surgery in the treatment of hypertensive cerebral hemorrhage. Computational and Mathematical Methods in Medicine. 2022; 2022: 7156598.

[22] Yang Y, Pan Y, Chen C, Zhao P, Hang C. Clinical significance of multiparameter intracranial pressure monitoring in the prognosis prediction of hypertensive intracerebral hemorrhage. Journal of Clinical Medicine. 2022; 11: 671.